ELAVL1 and breast cancer: HuR binds to the 3′UTR of ERBB2 and positively impacts its expression by increasing the stability of the transcripts, while upregulation of miR26a/b represses ERBB2 expression, thereby conferring higher sensitivity to tamoxifen in MCF7 breast cancer cell lines.